We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DE icon
351
PUT
Deere & Co
DE
$165B
$91M 0.06%
581,200
+81,000
+16% +$11.3M
BKU icon
352
Bankunited
BKU
$3.38B
$90.7M 0.06%
2,228,050
+2,065,582
+1,271% +$75.2M
WDAY icon
353
Workday
WDAY
$43B
$90.5M 0.06%
889,945
+446,637
+101% +$47.7M
TROW icon
354
T. Rowe Price
TROW
$23.8B
$90.5M 0.06%
+862,016
New +$84.1M
ETFC
355
DELISTED
E*Trade Financial Corporation
ETFC
$89.9M 0.05%
1,814,234
-306,405
-14% -$14.1M
PHG icon
356
Philips
PHG
$26B
$89.8M 0.05%
3,128,127
+1,603,393
+105% +$48.3M
AGN
357
CALL
DELISTED
Allergan plc
AGN
$89.7M 0.05%
548,100
+90,300
+20% +$16.2M
BERY
358
DELISTED
Berry Global Group, Inc.
BERY
$89.6M 0.05%
1,662,780
+452,460
+37% +$24.6M
SBUX icon
359
CALL
Starbucks
SBUX
$121B
$89.1M 0.05%
1,552,300
+353,100
+29% +$20M
RTN
360
DELISTED
Raytheon Company
RTN
$88.9M 0.05%
473,153
+459,886
+3,466% +$85.8M
AXS icon
361
AXIS Capital
AXS
$7.4B
$88.7M 0.05%
1,764,644
+1,652,402
+1,472% +$88M
MNST icon
362
Monster Beverage
MNST
$89.1B
$88.6M 0.05%
5,602,024
-1,165,176
-17% -$17.4M
VXX
363
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$88.5M 0.05%
3,170,800
+723,600
+30% +$23.9M
TGT icon
364
PUT
Target
TGT
$69.1B
$87.8M 0.05%
1,345,100
+82,400
+7% +$4.97M
XOM icon
365
ExxonMobil
XOM
$653B
$87.5M 0.05%
1,046,331
+927,937
+784% +$76.7M
HYG icon
366
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$86.9M 0.05%
995,600
-384,800
-28% -$33.8M
BHC icon
367
PUT
Bausch Health
BHC
$2.29B
$86.8M 0.05%
4,175,100
+1,873,600
+81% +$29.7M
FXI icon
368
PUT
iShares China Large-Cap ETF
FXI
$4.21B
$86.6M 0.05%
1,874,800
-801,300
-30% -$37M
APC
369
PUT
DELISTED
Anadarko Petroleum
APC
$86.2M 0.05%
1,606,100
+806,800
+101% +$39.7M
VST icon
370
Vistra
VST
$49.4B
$86.1M 0.05%
4,699,992
+4,314,196
+1,118% +$80.8M
SHPG
371
DELISTED
Shire pic
SHPG
$86.1M 0.05%
554,736
-267,644
-33% -$39.7M
UNH icon
372
PUT
UnitedHealth
UNH
$363B
$85.8M 0.05%
389,200
+95,600
+33% +$20.3M
GOOG icon
373
Alphabet (Google) Class C
GOOG
$4.18T
$85.7M 0.05%
1,637,840
-1,477,840
-47% -$75.2M
EA
374
PUT
DELISTED
Electronic Arts
EA
$85.4M 0.05%
813,200
+428,700
+111% +$47.7M
TSN icon
375
Tyson Foods
TSN
$19.6B
$85.4M 0.05%
1,053,142
-2,511,958
-70% -$192M

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.